Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Stomach Neoplasms 14 Prostatic Neoplasms 13 Colorectal Neoplasms 13 Neoplasms 12 Pancreatic Neoplasms 10 Endometrial Neoplasms 9 Carcinoma, Non-Small-Cell Lung 9 Breast Neoplasms 9 Lung Neoplasms 7 Colonic Neoplasms 7 Neoplasm Metastasis 6 Carcinoma, Hepatocellular 6 Oropharyngeal Neoplasms 5 Multiple Myeloma 5 Mouth Neoplasms 5 Lymphoma, Large B-Cell, Diffuse 5 Sarcoma 4 Recurrence 4 Rectal Neoplasms 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 Esophageal Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 3 Melanoma 3 Lymphoma, Non-Hodgkin 3 Lymphoma, Mantle-Cell 3 Lymphoma, Follicular 3 Leukemia, Myeloid, Acute 3 Head and Neck Neoplasms 3 Gastrointestinal Stromal Tumors 3

Interventions

Radiotherapy 7 Brachytherapy 6 Surveys and Questionnaires 4 Magnetic Resonance Spectroscopy 4 durvalumab 3 Radiosurgery 3 Methods 3 tremelimumab 2 aldesleukin 2 Topotecan 2 Radiation 2 Palliative Care 2 Paclitaxel 2 Immunoglobulin G 2 Gemcitabine 2 Early Intervention, Educational 2 Disulfides 2 Dehydroepiandrosterone 2 Counseling 2 Capecitabine 2 Bevacizumab 2 Behavior Therapy 2 Adoptive Transfer 2 zimberelimab 1 temsirolimus 1 talazoparib 1 rocakinogene sifuplasmid 1 liposomal doxorubicin 1 fludarabine phosphate 1 dostarlimab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Vaginal Neoplasms × Observation × Clear all

NCT06514235 2025-08-19

EMBRAVE

Erasmus Medical Center

Vaginal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡